Author: patriciagallego
Tamoxifen vs. Aromatase Inhibitors – How do they work?
Both tamoxifen and aromatase inhibitors are hormonal therapies used in the treatment of oestrogen positive breast cancers to stop tumour growth and recurrence.
To PRO or not to PRO? That’s not the question
The current pandemic has put enormous pressures on cancer care. The role of e-Health technologies in the management of cancer care is becoming more vital than ever.
To PRO or not to PRO? That’s not the question
The current pandemic has put enormous pressures on cancer care. The role of e-Health technologies in the management of cancer care is becoming more vital than ever.
OWise breast cancer listed in the Top 25 of all health apps by IQVIA.
OWise breast cancer was listed in the Top 25 of all health apps by IQVIA.
Evaluating the value of supportive medical apps during the treatment for breast cancer
Young-Afat et al, 2014; Amsterdam EBCC9.
First place in the Digital Health Masterclass Challenge 2013
Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.
NHS Innovation Accelerator
Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands to develop OWise in 2015. The NIA is facilitating Anne’s … Continue reading “NHS Innovation Accelerator”
Optimising oncology outcomes with a mobile app for breast cancer patients: A qualitative evaluation.
2016 NCRI Conference
Is there value in using patient recorded outcome measures to improve toxicity management patients receiving chemotherapy for breast cancer?
2017 Annual British Oncology Pharmacy Association Symposium
Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App
Px HealthCare (Px), the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence (RWE) study at the San Antonio Breast Cancer Symposium (SABCS).
OWise receives top prize in Scotland’s Cancer Innovation Challenge
OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!
OWise wins top NESTA Healthier Lives Data Fund Prize
Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland.